Friday, 27 May 2016 22:37

Spin-off from RWTH Aachen manufactures alternative cell culture medium Featured

In collaboration with biologists at the Rheinisch-Westfälische Technische Hochschule Aachen (RWTH Aachen University), a start-up company produces an alternative cell medium to fetal calf serum for regenerative therapies. Instead of blood from unborn calves human platelets from blood banks are used.

The molecular biologist and former RWTH scientist, Dr. Hatim Hemeda produces its serum from platelet concentrates of blood banks. He gets the row material from numerous suppliers german-wide. The young entrepreneur founded his company PL BioScience GmbH in 2015 in collaboration with Christian Wilkes, who is responsible for the economic sector.

A strong support came from the RWTH business college and Professor Wolfgang Wagner, in whose group "Stem Cell Biology and Cellular Engineering" he has developed his method. Here, als scientists work exclusively with platelet lysates. This substance is also a starting material for a 3D matrix in which cells feel much more comfortable than on the hard surface of cell culture plastic bottles - an invention of Wagner´s research group. The invention is patent pending, as scientists report in a today's press release.

In addition to the liquid medium PLSOLUTION, which is distributed in two qualities, a second from RWTH in-licensed Spin-off product is PLMATRIX. More than 250 platelet donations are pooled for a production unit.

Source and further information:
http://www.rwth-aachen.de/cms/root/Die-RWTH/Aktuell/Pressemitteilungen/Mai/~lfgz/Spin-off-der-RWTH-macht-Verzicht-auf-Kae/
http://www.pl-bioscience.com/
http://www.ukaachen.de/kliniken-institute/institut-fuer-zellbiologie/institute/division-of-stem-cell-biology-and-cellular-engineering/team/prof-wagner.html